Compare ADMA Biologics Inc (ADMA) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs SkyWest Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while SkyWest Inc trades at $108.98 (market cap $4.19B). The key difference: SkyWest Inc is the larger of the two by market cap, and SkyWest Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | SKYW | |
|---|---|---|
Market Cap | $2.22B | $4.19B |
Sector | Health | Technology |
52-Week High | $20.38 | $123.72 |
52-Week Low | $7.60 | $78.40 |
Enterprise Value | $2.29B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
